Mizuho initiates coverage on NeuroPace with Outperform rating
Mizuho analyst Anthony Petrone has initiated coverage on NeuroPace with an Outperform rating and a price target of $22.

*this image is generated using AI for illustrative purposes only.
Mizuho analyst Anthony Petrone has initiated coverage on NeuroPace with an Outperform rating and a price target of $22. The rating reflects a positive outlook on the company's performance.
Analyst Details
The coverage was initiated by Mizuho, targeting a price of $22 for NeuroPace shares.
What specific factors drove Mizuho's decision to set a $22 price target for NeuroPace?
How might NeuroPace's recent performance or pipeline developments support the Outperform rating?
What are the potential risks or challenges that could hinder NeuroPace from reaching the $22 target?
























